Eisai Seeks Accelerated Approval for Alzheimer’s Drug Lecanemab
The biotechnology company Eisai Co., Ltd. announced a rolling submission for accelerated approval from the Food and Drug Administration for their anti-amyloid Alzheimer’s treatment,…
The biotechnology company Eisai Co., Ltd. announced a rolling submission for accelerated approval from the Food and Drug Administration for their anti-amyloid Alzheimer’s treatment,…
Scientists are looking toward microglia cells as therapeutic targets for Alzheimer’s. Microglia, known as the janitors of our brains, are responsible for clearing harmful…
Using the blue device (pictured) that performs the ultrasensitive proximity extension assay technology, Professor Nancy Ip Yuk-Yu and her team have developed a blood…
We know that brains benefit from being put to work. Increasingly, researchers are looking at gaming and brain health. Some games are designed specifically…
Researchers share insights on the infectious theory of Alzheimer’s—the idea viruses and bacteria may cause Alzheimer’s. Clinical trials are underway to test this theory….
Megan, a 36-year-old special education teacher in Pennsylvania, felt honored to care for two of her grandparents who were living with Alzheimer’s. But over…
Swimming gives your brain a boost – but scientists don’t know yet why it’s better than other aerobic activities. Seena Mathew, assistant professor of biology…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Image courtesy of Fayron Epps. One day,…
The onset of dementia symptoms can upturn careers and relationships. Both the present and future are often filled with uncertainties. Coming to terms with…
A study finds that people who struggle to hear over background noise had as much as a 91-percent higher risk of dementia. Thomas Littlejohns,…
Studies have shown: Games can be good for the brain. Jigsaw, crosswords, and number puzzles have been found to improve cognitive function in older…
Nikki Schultek, founder of the global medical research consortium Intracell Research Group, takes a close look at how the COVID-19 pandemic may prompt a…
Early data presented by Cassava Sciences demonstrates the safety of their Alzheimer’s drug simufilam, which is currently in Phase 3 clinical trials. But in late…
Alzheimer’s is a complex disease, and studies that follow participants over extended periods of time can gather troves of data on the progression of…
University of Montreal neuropsychology PhD student Émilie Delage, University of Quebec at Montreal professor of psychology and neuropsychology Isabelle Rouleau and University of Montreal…